Kyntra Bio, Inc.
KYNB· Nasdaq
KYNBKyntra Bio, Inc.
Filed Aug 8, 2016 · 10-Q · 39 days after period end · 0001564590-16-023280
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Revenue | $89.28M | $120.55M | $89.96M |
| Net Income | $24.32M | $57.06M | $46.83M |
| EPS Diluted | $0.35 | $0.83 | $0.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 8, 2016 · 39 d after period end
